Blood Research

Download original image

Table 3 Literature review on rituximab plus alkylating regimens.

Abbreviations: DRC, dexamethasone, rituximab, and cyclophosphamide; FN, febrile neutropenia; G, grade; M, median; NA, not applicable; ORR, overall response rate; PFS, progression-free survival; PN, peripheral neuropathy; R-CHOP, rituximab, cyclophosphamide, hydroxy-doxorubicin, vincristine, and prednisone; Ref No., reference number; TTF, time to treatment failure; TTP, time to progression.

Blood Res 2018;53:117~122 https://doi.org/10.5045/br.2018.53.2.117
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd